Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120117) titled 'Sandalwood-mediated OR2AT4 activation regulates paracrine signaling to ameliorate dermal papilla vascular degeneration in androgenetic alopecia' on March 10.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: West China Hospital, Sichuan University

Condition: androgenetic alopecia

Recruitment Status: Not Recruiting

Phase: 0

Date of First Enrollment: 2024-10-31

Target Sample Size: Sandalore/santalol treatment group:30;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=261308

Disclaimer: Curated by HT Syndication....